某种肠道细菌
普氏粪杆菌
益生元
菊粉
微生物学
医学
生物
肠道菌群
食品科学
粪便
免疫学
作者
Sanne Verhoog,Petek Eylül Taneri,Zayne Milena Roa‐Díaz,Pedro Marques‐Vidal,J. P. Troup,Lia Bally,Oscar H. Franco,Marija Glišić,Taulant Muka
出处
期刊:Nutrients
[MDPI AG]
日期:2019-07-11
卷期号:11 (7): 1565-1565
被引量:100
摘要
Akkermansia muciniphila and Faecalibacterium prausnitzii are highly abundant human gut microbes in healthy individuals, and reduced levels are associated with inflammation and alterations of metabolic processes involved in the development of type 2 diabetes. Dietary factors can influence the abundance of A. muciniphila and F. prausnitzii, but the evidence is not clear. We systematically searched PubMed and Embase to identify clinical trials investigating any dietary intervention in relation to A. muciniphila and F. prausnitzii. Overall, 29 unique trials were included, of which five examined A. muciniphila, 19 examined F. prausnitzii, and six examined both, in a total of 1444 participants. A caloric restriction diet and supplementation with pomegranate extract, resveratrol, polydextrose, yeast fermentate, sodium butyrate, and inulin increased the abundance of A. muciniphila, while a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols decreased the abundance of A. muciniphila. For F. prausnitzii, the main studied intervention was prebiotics (e.g. fructo-oligosaccharides, inulin type fructans, raffinose); seven studies reported an increase after prebiotic intervention, while two studies reported a decrease, and four studies reported no difference. Current evidence suggests that some dietary factors may influence the abundance of A. muciniphila and F. prausnitzii. However, more research is needed to support these microflora strains as targets of microbiome shifts with dietary intervention and their use as medical nutrition therapy in prevention and management of chronic disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI